![Huw Nash](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Huw Nash
Private Equity Investor bei
Petrichor Scion Therapeutics Management LLC
Profil
Huw M.
Nash was the founder of Rein Therapeutics, Inc. since 2001, holding the title of Vice President-Corporate Development from 2001 to 2013.
Dr. Nash is currently a Venture Partner at Petrichor Scion Therapeutics Management LLC since 2024.
Former positions include Chief Executive Officer at Stoke Therapeutics, Inc. from 2014 to 2017 and VP-External Collaborations & Founding Scientist at NeoGenesis Pharmaceuticals, Inc. from 1997 to 2005.
Education includes a doctorate from Harvard University and an undergraduate degree from Harvard College.
Aktive Positionen von Huw Nash
| Unternehmen | Position | Beginn |
|---|---|---|
Petrichor Scion Therapeutics Management LLC
 Petrichor Scion Therapeutics Management LLC Investment ManagersFinance Petrichor Scion Therapeutics Management LLC is an active manager. | Private Equity Investor | 01.10.2024 |
Ehemalige bekannte Positionen von Huw Nash
| Unternehmen | Position | Ende |
|---|---|---|
| REIN THERAPEUTICS INC. | Gründer | 01.01.2013 |
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Corporate Officer/Principal | 01.01.2005 |
| STOKE THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.10.2017 |
Ausbildung von Huw Nash
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Petrichor Scion Therapeutics Management LLC
Petrichor Scion Therapeutics Management LLC Investment ManagersFinance Petrichor Scion Therapeutics Management LLC is an active manager. | Finance |
Wählen Sie MarketScreener 
